Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association

Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinolo...

Full description

Bibliographic Details
Main Authors: Henry B Burch, Petros Perros, Tomasz Bednarczuk, David S Cooper, Peter J Dolman, Angela M Leung, Ilse Mombaerts, Mario Salvi, Marius N Stan
Format: Article
Language:English
Published: Bioscientifica 2023-01-01
Series:European Thyroid Journal
Subjects:
Online Access:https://etj.bioscientifica.com/view/journals/etj/11/6/ETJ-22-0189.xml
_version_ 1828064822795698176
author Henry B Burch
Petros Perros
Tomasz Bednarczuk
David S Cooper
Peter J Dolman
Angela M Leung
Ilse Mombaerts
Mario Salvi
Marius N Stan
author_facet Henry B Burch
Petros Perros
Tomasz Bednarczuk
David S Cooper
Peter J Dolman
Angela M Leung
Ilse Mombaerts
Mario Salvi
Marius N Stan
author_sort Henry B Burch
collection DOAJ
description Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this Consensus Statement.
first_indexed 2024-04-10T23:04:37Z
format Article
id doaj.art-76691c55701645b19f76590849948f3d
institution Directory Open Access Journal
issn 2235-0802
language English
last_indexed 2024-04-10T23:04:37Z
publishDate 2023-01-01
publisher Bioscientifica
record_format Article
series European Thyroid Journal
spelling doaj.art-76691c55701645b19f76590849948f3d2023-01-13T12:54:55ZengBioscientificaEuropean Thyroid Journal2235-08022023-01-01116137https://doi.org/10.1530/ETJ-22-0189Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid AssociationHenry B Burch0Petros Perros1Tomasz Bednarczuk2David S Cooper3Peter J Dolman4Angela M Leung5Ilse Mombaerts6Mario Salvi7Marius N Stan8National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA; Endocrinology Division, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA Department of Endocrinology, Leazes Wing, Royal Victoria Infirmary, Newcastle upon Tyne, United KingdomDepartment of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, PolandDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USADepartment of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, CanadaDivision of Endocrinology, Diabetes, and Metabolism, Department of Medicine, UCLA David Geffen School of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, California, USADepartment of Ophthalmology, University Hospitals Leuven, Leuven, BelgiumDepartment of Clinical and Community Services, Graves’ Orbitopathy Center, Endocrinology, Fondazione IRCCS Cà Granda, Milan, ItalyDivision of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, Minnesota, USAThyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this Consensus Statement.https://etj.bioscientifica.com/view/journals/etj/11/6/ETJ-22-0189.xmlthyroid eye diseaseconsensus statementamerican thyroid associationeuropean thyroid association
spellingShingle Henry B Burch
Petros Perros
Tomasz Bednarczuk
David S Cooper
Peter J Dolman
Angela M Leung
Ilse Mombaerts
Mario Salvi
Marius N Stan
Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association
European Thyroid Journal
thyroid eye disease
consensus statement
american thyroid association
european thyroid association
title Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association
title_full Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association
title_fullStr Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association
title_full_unstemmed Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association
title_short Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association
title_sort management of thyroid eye disease a consensus statement by the american thyroid association and the european thyroid association
topic thyroid eye disease
consensus statement
american thyroid association
european thyroid association
url https://etj.bioscientifica.com/view/journals/etj/11/6/ETJ-22-0189.xml
work_keys_str_mv AT henrybburch managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT petrosperros managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT tomaszbednarczuk managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT davidscooper managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT peterjdolman managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT angelamleung managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT ilsemombaerts managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT mariosalvi managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation
AT mariusnstan managementofthyroideyediseaseaconsensusstatementbytheamericanthyroidassociationandtheeuropeanthyroidassociation